NVRO
Nevro Corp. · NYSE
- Sector Health Technology
- Industry Medical Specialties
- Website nevro.com
- Employees(FY) 1087
- ISIN US64157F1030
Performance
-10.19%
1W
-10.61%
1M
-35.21%
3M
-56.98%
6M
-82.39%
YTD
-82.0%
1Y
Profile
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation system for the treatment of chronic pain, as well as Senza II and Senza Omnia SCS systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company's Senza HFX iQ IPG system includes HFX iQ implantable pulse generator, HFX trial stimulator, and HFX iQ patient remote, as well as HFX App, a patient remote control and the wireless trialing system. In addition, it offers surpass surgical and percutaneous leads. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California.
Technical Analysis of NVRO 2024-12-20
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-12-18 18:37
Nevro price target lowered to $4.70 from $7 at Truist(Yahoo Finance)
- 2024-12-17 03:30
- 2024-11-17 21:00
- 2024-11-17 19:30
- 2024-11-14 19:30
- 2024-11-12 17:23
- 2024-11-12 00:12
Q3 2024 Nevro Corp Earnings Call(Yahoo Finance)
- 2024-11-11 18:00
- 2024-11-11 04:20
Nevro (NVRO) Reports Q3 Loss, Tops Revenue Estimates(Yahoo Finance)
- 2024-11-11 03:15
Nevro: Q3 Earnings Snapshot(Yahoo Finance)
- 2024-11-11 03:05
- 2024-11-07 18:05
- 2024-10-29 04:30
- 2024-10-16 04:30
- 2024-10-10 04:45
- 2024-09-24 16:12
- 2024-09-23 20:00
- 2024-09-19 04:30
- 2024-09-11 13:20
- 2024-08-28 04:15
- 2024-08-20 01:04
Here's Why You Should Retain Nevro (NVRO) Stock for Now(Yahoo Finance)
- 2024-08-14 04:30
- 2024-08-13 05:13
- 2024-08-08 20:22
- 2024-08-07 13:38
Nevro considers sale as competition for pain market ramps up(Yahoo Finance)
- 2024-08-07 01:01
Nevro's (NVRO) Q2 Earnings Beat Estimates, Revenues Down Y/Y(Yahoo Finance)
- 2024-08-06 05:55
Nevro (NVRO) Reports Q2 Loss, Misses Revenue Estimates(Yahoo Finance)
- 2024-08-06 04:52
Nevro: Q2 Earnings Snapshot(Yahoo Finance)
- 2024-08-06 04:05
- 2024-07-11 04:15
Page 1 of 7
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.